Medicare Enrolled
Dr. Joshua Wein, MD
Optician · Cranford, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wein
Dr. Joshua Wein is an optician specialist in Cranford, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wein performed 3,815 Medicare services across 2,415 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wein received a total of $3,013 from 36 pharmaceutical and/or device companies across 176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in NJ
$3,013 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,815
Medicare services
Top 18% in NJ for optician
2,415
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~201 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,035 | $98 | $274 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
926 | $2 | $10 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
238 | $68 | $179 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
194 | $8 | $15 |
| PSA test (prostate cancer screening) | 150 | $18 | $76 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
131 | $112 | $336 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
123 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
121 | $8 | $34 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
115 | $214 | $890 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
114 | $9 | $115 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
103 | $18 | $76 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
100 | $135 | $412 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
88 | $93 | $381 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
57 | $8 | $33 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
56 | $8 | $13 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
31 | $51 | $425 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
25 | $28 | $112 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
24 | $110 | $1,443 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
24 | $25 | $106 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
23 | $617 | $4,090 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
21 | $5 | $21 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
21 | $21 | $81 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $63 | $188 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
18 | $8 | $319 |
| Insertion of temporary bladder tube | 16 | $40 | $326 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $346 | $2,290 |
| Complicated insertion of bladder tube | 14 | $65 | $400 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $496 | $5,085 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
6.6% medium
93.0% routine
Industry Payment Transparency
Open Payments through 2023 ↗$3,013
Total received (2018-2023)
Avg $502/year across 6 years
Top 26% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
176
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,890 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$141
2022
$27
2021
$828
2020
$456
2019
$798
2018
$763
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$122
Boston Scientific Corporation
$19
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Astellas Pharma US Inc
$770
PFIZER INC.
$343
Dendreon Pharmaceuticals LLC
$221
Bayer HealthCare Pharmaceuticals Inc.
$191
Janssen Biotech, Inc.
$178
PROCEPT BioRobotics Corporation
$139
Myovant Sciences Inc.
$127
Boston Scientific Corporation
$108
KOELIS Inc.
$99
Coloplast Corp
$91
Endo Pharmaceuticals Inc.
$71
Amgen Inc.
$70
AbbVie, Inc.
$64
Olympus America Inc.
$46
Medtronic USA, Inc.
$45
AstraZeneca Pharmaceuticals LP
$44
BOSTON SCIENTIFIC CORPORATION
$43
Allergan Inc.
$38
Merck Sharp & Dohme Corporation
$30
MEDIVATION FIELD SOLUTIONS LLC
$29
Myriad Genetic Laboratories, Inc.
$27
Teleflex LLC
$27
Blue Earth Diagnostics Limited
$26
Allergan, Inc.
$26
UROGEN PHARMA, INC.
$17
Verity Pharmaceuticals Inc.
$15
Mission Pharmacal Company
$15
180 Medical, Inc.
$15
SANOFI-AVENTIS U.S. LLC
$15
Metuchen Pharmaceuticals
$14
Hollister Incorporated
$13
Aytu BioScience, Inc
$12
Acerus Pharmaceuticals Corporation
$12
UROVANT SCIENCES INC
$12
Rochester Medical Corporation
$11
Zyla Life Sciences
$11
Top 3 companies account for 44.3% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · Androgel · AquaBeam Robotic System · Axumin · BOTOX · BRACANALYSIS CDX · CONTINENCE CARE · ERLEADA · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · INTERSTIM · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Natesto · Nubeqa · ORGOVYX · OXAYDO · PENILE & TESTICULAR RECONSTRUCTN · PREMARIN · PREMARIN ORALS · PROVENGE · PVC · Prolaris · Prolia · Rezum Generator · Stendra · TITAN · TOVIAZ · Trelstar · Trinity 3D Prostate Suite · Uribel · UroLift System · VISERA ELITE II VIDEO SYSTEM CENTER · VaPro · XGEVA · XIAFLEX · XTANDI · Xofigo · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
10,964
Per 100K population
1914.9
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wein is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wein performed 1,035 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wein receive payments from pharmaceutical companies?
Yes. Dr. Wein received a total of $3,013 from 36 companies across 176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wein's costs compare to other opticians in Cranford?
Dr. Wein's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Cranford
Browse opticians in Cranford ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology